LPS interacts with toll-like receptor (TLR)-4 through binding to the co-receptor myeloid differentiation protein-2 (MD-2), resulting in downstream inflammatory events, which may be responsible for the development of metabolic diseases [35,36]. The gene discussed is TLR4; the disease is metabolic disease.